STAAR Surgical climbs after Alcon announces amended merger deal

Shares of medical device maker STAAR Surgical STAA.O rise 10.4% to $25.6 premarket

Swiss eye-care firm Alcon ALCC.S says it has entered into an amended merger agreement to acquire STAAR Surgical Company

Under the amended agreement, Alcon will purchase all outstanding shares of STAAR for $30.75 per share in cash

Alcon says the deal represents a total equity value of about $1.6 billion

Deal is anticipated to close in early 2026

Alcon expects the transaction to be accretive to earnings in year two

Up to last close, STAA was down 3.1% YTD